scholarly journals Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics

2021 ◽  
Author(s):  
John E. Jett ◽  
Michael McLaughlin ◽  
Mark S. Lee ◽  
Lawrence Charles Parish ◽  
Janet DuBois ◽  
...  
Keyword(s):  
Plaque Psoriasis

Biologics Compared For Plaque Psoriasis

2007 ◽  
Vol 38 (11) ◽  
pp. 9
Author(s):  
BRUCE JANCIN
Keyword(s):  
Plaque Psoriasis

First "Real-World" Insights on Apremilast Treatment for Patients with Plaque Psoriasis from the LAPIS-PSO Study: An Interim Analysis

2017 ◽  
Vol 1 ◽  
pp. s15 ◽  
Author(s):  
Kristian Reich ◽  
Stefanie Bomas ◽  
Bernhard Korge ◽  
Maria Manasterski ◽  
Uwe Schwitchtenberg ◽  
...  
Keyword(s):  
Real World ◽  
Plaque Psoriasis ◽  
Interim Analysis

Abstract Not Available Disclosure: Study supported by Celgene.

Patient-reported outcomes in subjects with plaque psoriasis treated with tapinarof cream: Results from a phase 2b, randomized parallel-group study

2018 ◽  
Vol 2 ◽  
pp. S85
Author(s):  
Neal Bhatia ◽  
David Rubenstein ◽  
Anna M Tallman ◽  
James Lee
Keyword(s):  
Plaque Psoriasis ◽  
Patient Reported Outcomes ◽  
Parallel Group Study ◽  
Parallel Group ◽  
Patient Reported

Abstract not available. Disclosures: Study sponsored by Dermavant.Copyright 2018 SKIN

Real World Patient Perceptions of the use of Calcipotriene Foam 0.005% in the Treatment of Plaque Psoriasis

2019 ◽  
Vol 3 ◽  
pp. S19
Author(s):  
Francisco Kerdel ◽  
Christina Don ◽  
Renata Block ◽  
Caitlin Lewis ◽  
Rhonda Schreiber
Keyword(s):  
Real World ◽  
Plaque Psoriasis ◽  
Patient Perceptions

Abstract not available.

Sign in / Sign up

Export Citation Format

Share Document